Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications
US12036220B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2023 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Apr 3, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6923
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD by lyophilizing a flash frozen stock solution of LSD and excipients, including a non-gelling matrix former, filler, and binder in a pre-formed mold, and forming an orally disintegrating tablet. A method of treating an individual by administering a solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet and treating the individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.